These findings made us think that the streptozocin application might cause changes in the NGF and Trk-A levels by the islet cell damage and cellular damage occurring in the islets of Langerhans in the diabetes disease that negatively affected the Trk-A receptor level. Here, NTRK1 is linked to diabetes mellitus.